Author Archives: Pete Guither

I received a note from Andrea Cavanaugh, the public outreach associate for Stop Prisoner Rape, a national human rights organization. Stories from Inside SPR is launching a groundbreaking new project built around firsthand accounts of sexual assaults against inmates held … Continue reading →

“bullet” DEA’s Karen Tandy is speaking out. This release from the DEA has her article: “Marijuana: The Myths Are Killing Us,” which appeared in the March issue of Police Chief Magazine. She starts by using the death of a 14-year-old … Continue reading →

Some of you may remember my report on the recent circus in Alaska where politicians sought to out-do themselves coming up with bogus information and outright lies about marijuana — part of an attempt by Alaska Governor Murkowski to over-ride … Continue reading →

Again today, the Supreme Court Justices released their opinions and Raich v. Ashcroft wasn’t there. Now there’s nothing that requires them to release their opinion on a certain date or in a certain order, but they will need to finish … Continue reading →

The Baltimore Sun reported Sunday, about a convention of a very interesting coalition: Yesterday, representatives of 15 black professional organizations that formed the National African American Drug Policy Coalition in the fall met to devise a strategy for changing drug … Continue reading →

I thought it would be good to recap just a few of the major events in drug policy reform that are in the works. The Supreme Court Decision in Raich v. Ashcroft. The next possible dates for a decision are … Continue reading →

Daksya has a diary entry over at Nephalim’s Drug War Revealed asking whether people think drug use would increase a little, a lot, or none under legalization. Go give your opinion.

The Marijuana Policy Project reports that they will hold a telephone press conference today at noon to discuss “developments in the effort to overcome Drug Enforcement Administration obstruction of medical marijuana research.” Participating: Lyle Craker, Ph.D., director, medicinal plant program, … Continue reading →

I just noticed Mark Kleiman’s post about Sativex. He does a fairly good job of summarizing the situation, and talks about how the advent of Sativex may affect the framing of the debate on both sides of the medical marijuana … Continue reading →

Thanks for all the notes and responses recently regarding a whole lot going on in the world of drug policy. On a personal note, the last couple of days have been extremely busy for me (in good ways), so I … Continue reading →